The objective of the study was to evaluate the expression of Lselectin ligands in tubal epithelia during tubal ectopic pregnancy. Sixteen fallopian tube samples from ectopic pregnancies and four normal control fallopian tubes from women undergoing sterilization were obtained for the study. Oviduct tissues from ectopic pregnancies were separated into implantation sites and matched nonimplantation sites. Expression of L-selectin ligands was evaluated by immunohistochemistry with antibodies against HECA-452 and MECA-79 and by real-time PCR. Immunoreactivity levels against HECA-452 and MECA-79 were significantly higher at the implantation site than at the paired nonimplantation site or at the normal oviducts. Moreover, compared with MECA-79 staining, stronger HECA-452 staining was observed in the implantation and nonimplantation groups. HECA-452 histologic scores at implantation sites correlated with serum human chorionic gonadotropin levels. Increased expression of Lselectin ligands may be involved in the implantation process in tubal pregnancy. ectopic pregnancy, fallopian tube, implantation, L-selectin ligands, receptivity
INTRODUCTION
In more than 95% of ectopic pregnancies, the fertilized ovum implants in the fallopian tubes [1] . It is likely that tubal implantation is caused by embryo retention within the fallopian tube due to deregulated embryotubal transport and alterations in the tubal microenvironment, allowing implantation to occur [2] . Changes in the tubal environment include abnormal expression of cytokines such as leukemia inhibitory factor (LIF) and interleukin (IL)-1 and IL-8, and adhesion molecules such as integrins and mucin I, and changes in the innate immune system [2] . All these alterations signal the establishment of a ''receptive tubal epithelium,'' both suitable for and capable of implantation. Selectin adhesion molecules, which mediate the early stage of blastocyst attachment, are important molecules that reflect endometrial receptivity during the window of implantation [3, 4] . However, their roles in ectopic pregnancy are still unknown.
Selectins are a group of cell adhesion molecules that include P-selectin (CD62P), L-selectin (CD62L), and Eselectin (CD62E). All selectins are glycoproteins that contain 30% or more carbohydrates [5] . The initial attachment of an embryo to the endometrium depends on the binding of Lselectin, expressed by the trophoblast to oligosaccharidebased ligands expressed by the endometrium [4] . Thus, interactions between L-selectins and their respective ligands in the endometrium may act as a bridge in the initial attachment required for implantation [6] . L-Selectins are bound by lowaffinity sialyl Lewis x (sLex)-decorated ligands (recognized by HECA-452), and sulfation of sLex-terminated glycans at the 6-position of GlcNAc (recognized by MECA-79) activates the epitope to act as a high-affinity ligand for L-selectin [7, 8] . HECA-452 and MECA-79 are upregulated when the endometrium becomes receptive during the window of implantation [4, [9] [10] [11] . However, it has been shown that the maximal increase in expression of MECA-79 in fertile patients occurs from proliferative to secretory phase endometrium, indicating the role of sulfated carbohydrate ligands as the major ligands for L-selectin in the uterus [10] . The distribution pattern of Lselectin ligands in ectopic pregnancy remains to be elucidated.
We hypothesized that L-selectin ligands play a significant role in the apposition and attachment of the embryo to the ''receptive tubal epithelia'' during ectopic implantation. If expression of L-selectin ligands is important in determining tubal epithelia receptivity, then alterations in their expression could contribute to tubal pregnancy. The objective of this study, therefore, was to evaluate the intensity and distribution pattern of L-selectin ligands in the tubal epithelia during tubal ectopic pregnancy.
MATERIALS AND METHODS

Human Tissue Collection
All patients signed informed consent letters, and complete institutional review board approval for this study was obtained from the Shanghai Jiaotong University affiliated First People's Hospital. From July to October 2010, 16 patients (ages 24-35 yr old; median, 30 yr) who underwent salpingectomy for tubal pregnancy at the Shanghai Jiaotong University affiliated First People's Hospital were enrolled. All recruited patients met the following criteria: (1) a previous normal intrauterine pregnancy, regular menses, and an accurate previous menstrual period; (2) no exogenous hormone treatment or intrauterine device used within the 3 mo before surgery; (3) no co-intrauterine pregnancy defined by transvaginal ultrasonography scans of the pelvis and no methotrexate treatment before surgery for patients with tubal pregnancy. Gestational age was determined using the date of commencement of the last menstrual period. The histories of patients are shown in Table 1 . Samples from the implantation site (the area within 5 mm of the gestational mass) and the nonimplantation site (more than 20 mm beyond the gestational mass) were collected separately. The embryos were excluded from the samples before further investigation. In parallel, fallopian tube specimens from four women ages 25-40 yr old (medium, 32 yr old) undergoing tubal ligation in the luteal phase were collected as controls. Each tubal sample was divided into two parts: one part was snap-frozen in liquid nitrogen and stored at À808C for quantitative PCR, and the other part was placed in 10% buffered formalin (pH 7.4) for 16-24 h and then embedded in paraffin for immunohistochemical analysis and confirmation by subsequent pathological analysis. Purified rat anti-mouse peripheral lymph node addressin (PNAd), carbohydrate epitope monoclonal antibody (MECA-79; Santa Cruz Biotechnology, Santa Cruz, CA), and purified rat anti-human cutaneous lymphocyte antigen (CLA) monoclonal antibody (HECA-452; Santa Cruz Biotechnology) were used to determine the expression of L-selectin ligands.
Immunohistochemistry
Samples were fixed in 10% buffered formaldehyde for 24 h, embedded in paraffin, and sectioned (3-to 4-mm thickness) on positively charged slides for immunohistochemical (IHC) studies. Sections were de-waxed with xylene and descending grades of methanol and distilled water and incubated with rat antihuman L-selectin ligand monoclonal antibodies (1:50 dilution in phosphatebuffered saline [PBS] for 2 h) at room temperature. Binding of MECA-79 or HECA-452 was detected with a biotinylated rabbit anti-mouse secondary antibody (1:1000 dilution in PBS), followed by horseradish peroxidaseconjugated avidin-biotin peroxidase. Slides were counterstained with hematoxylin. Positive control sections of tonsil tissues were used. Negative controls were treated identically except that the primary staining procedure was carried out in the absence of antibody.
Two independent readers, blinded to group information, evaluated IHC sections by histologic score (H-score), using a Laborlux model microscope (Leitz, Wetzlar, Germany). HECA-452 and MECA-79 staining of tubal epithelium was graded semiquantitatively, and the H-score was calculated using the equation H-score ¼ P Pi (i þ 1), where i ¼ intensity of staining with a value of 1 (weak), 2 (moderate), or 3 (strong), and Pi is the percentage of stained epithelial cells at each intensity, from 0 to 100% [12] . Representative sections were photographed using a digital camera (Olympus, Center Valley, NJ) at 3100 and 3400 magnifications. 0 -ACTTTGGTATCGTGGAAGGACT CAT-3 0 (sense) and 5 0 -GTTTTTCTAGACGGCAGGTCAGG-3 0 (antisense), which generated a 255-bp fragment.
RNA Isolation and Real-Time PCR
Gene expression levels were normalized using the endogenous control gene GAPDH, and relative gene expression was determined using the 2(ÀDDCt) method. The formulae are as follows:
Statistical Analysis
Data distributions were assessed for normality using the Ryan-Joiner and Kolmogorov-Smirnov tests. HECA-452 and MECA-79 epitope expression levels in fallopian tubes followed a nonparametric distribution and were expressed as medians and ranges. The Kruskal-Wallis nonparametric test was used to compare staining intensities. For data with a normal distribution (RT-PCR results), an ANOVA test was used to determine significant differences between groups. All analysis was conducted using Statistical Package for the Social Sciences version 15.0 software (Chicago, IL). Differences were considered statistically significant at a P level of ,0.05.
RESULTS
IHC Localization and HECA-452 and MECA-79 Intensity in Tubal Ectopic Pregnancy
In the tubal ectopic pregnancy samples, HECA-452 and MECA-79 antibody reactivity localized to the luminal and glandular epithelium, with no visible expression in the stroma. Expression was observed predominantly at the cell membrane with little cytoplasmic staining (Fig. 1) . A different intensity of staining was observed for HECA-452 than for MECA-79, with higher intensity staining for HECA-452 in the implantation and nonimplantation groups.
HECA-452 staining at the implantation sites was more intense than matched nonimplantation sites or normal fallopian tubes (H ¼ 7.13 vs. 0.55, respectively, P , 0.001) (Fig. 2a) . Similarly, a significant increase in MECA-79 staining intensity was seen in implantation site epithelia compared to that in nonimplantation sites (H ¼ 2.62 vs. 0.50, respectively, P , 0.001) (Fig. 2b) . No evidence of HECA-452 or MECA-79 epitope expression was found in normal tubal epithelia.
HECA-452 and MECA-79 Epitope mRNA Expression in Human Fallopian Tubes
Whether transcripts for sulfotransferases associated with selectin ligand generation were expressed by oviduct was assessed by real-time PCR amplification. L-Selectin ligands require sulfation as a post-translational modification. Six sulfotransferases were potentially involved in the generation of selectin ligands. These enzymes can sulfate either protein (tyrosylprotein sulfotransferase [TPST]) or carbohydrate (carbohydrate sulfotransferase [CHST]) moieties [13] . Moreover, Core1-b3GlcNAcT and its cognate core-1 O-glycans are essential participants of MECA-79 epitope [14] . The carbohydrate structures of the HECA-452 and MECA-79 epitopes are shown in Figure 3 [15] . Compared with the normal control and nonimplantation sites, the implantation sites expressed high levels of CHST2, CHST3, and B3GNT (Fig. 4) , suggesting the possibility that CHST2, CHST3, and B3GNT were implicated LI ET AL. 
Correlation Between Serum hCG Levels and HECA-452 HScores at Implantation Sites
HECA-452 H-scores at implantation sites correlated with serum hCG levels (r ¼ 0.741), as shown in Figure 5 . No correlation was found between MECA-79 H-scores and serum hCG levels.
DISCUSSION
MECA-79 and HECA-452 antigens were widely distributed on luminal and glandular endometrial epithelia in the human uterus. High expression of the MECA-79 antigen in the secretory endometrium is associated with better endometrial receptivity and facilitation of embryo implantation in humans, whereas HECA-452 staining is significantly stronger in the glands in polycystic ovary syndrome (PCOS) and endometriosis patients than in fertile women [9] . Here we showed high levels of HECA-452 staining in tubal epithelia of women with ectopic pregnancies and low levels of MECA-79 staining. HECA-452 antigen expression at implantation sites was more Quantitative real-time PCR showed that CHST2 mRNA expression was 7.3-fold elevated at the implantation site compared with that at the nonimplantation site (P , 0.01), CHST3 mRNA expression was 22-fold elevated (P , 0.001), and B3GNT mRNA expression was 23-fold elevated (P , 0.001). No significant differences were found between these mRNAs at the nonimplantation site and normal oviducts. *P , 0.01 compared with nonimplantation site. **P , 0.001 compared with nonimplantation site.
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intense than that at matched nonimplantation sites or in normal fallopian tubes. This observation suggests that the HECA-452 epitope is active in tubal implantation during tubal pregnancy. However, only mild staining of MECA-79 was found at implantation sites in the fallopian tube. In contrast, both HECA-452 and MECA-79 are upregulated when the endometrium becomes receptive during the window of implantation. Although the mechanism of this unique distribution of Lselectin ligands in tubal pregnancy is unknown, this result may indicate low implantation capability in tubal epithelia because of the predominating abundance of low-affinity ligands over high-affinity ligands
The ''tubal implantation window'' has been proposed by several investigators, during which time the tubal epithelium is susceptible to ectopic implantation [16] [17] [18] . The integrins a1b1, a4b1, and avb3 are likely to be differentially expressed during the menstrual cycle; in particular, increased expression of the b3 subunit is likely in the luteal phase [16] [17] [18] . However, a recent study showed no cyclic changes in integrin expression within human fallopian tubes [19] . Thus, the existence of the tubal implantation window remains to be established. In the current study we showed that the antigens HECA-452 and MECA-79 were not expressed at either the protein or mRNA levels in normal tubal epithelia in the luteal phase, although differences in the expression of L-selectin ligands at different phases of the menstrual cycle were not investigated. Thus, our result may not support the existence of the tubal implantation window, as selectin adhesion systems importantly reflect receptivity during the window of implantation [20] . The mechanisms for the upregulation of L-selectin ligands in ectopic pregnancy are still unknown. However, it can be speculated that cross-talk between the retained embryo and the tubal epithelia may stimulate the expression of Lselectin ligands. Further studies to investigate the potential factors responsible for modification of L-selectin ligands will further clarify this issue.
Our experiment showed a positive correlation between serum hCG levels and HECA-452 H-scores at implantation sites. This result highlights the significance of HECA-452 expression at the fallopian tube and the occurrence of tubal ectopic pregnancy.
We have postulated [21] , as have other investigators [22] , that the cause of ectopic pregnancy is changing. That is, instead of ''passive'' retention within the fallopian tube, the preimplantation embryo may actively participate in locating a suitable implantation site. L-Selectin and its ligand mediate the initial apposition of human blastocysts to the receptive epithelia. Thus, it is reasonable to speculate that the overexpression of L-selectin ligands in the tube is caused by factors secreted from the ''active'' blastocysts. We are currently investigating one possible candidate, hCG. Nonetheless, the influence of other factors (i.e., inflammatory factors) produced by the tubal epithelia cannot be ruled out.
To our knowledge, this is the first report that demonstrates mRNA and protein expression of L-selectin ligands in the fallopian tube. This study highlights the potential importance of the relative abundance of L-selectin ligands and, in particular, the specific HECA-452 component present at the tubal implantation site. The inverse pattern of expression of Lselectin ligands in the fallopian tube compared with that in the endometrium may be a factor that contributes to the cause of ectopic pregnancy.
